Key result
Heparin has numerous pharmacologic limitations in percutaneous coronary intervention, including variable pharmacokinetics, inability to inhibit clot-bound thrombin, and risk of HIT.
Design
Editorial
Loading...
The text highlights the pharmacologic limitations of heparin in percutaneous coronary intervention, advocating for a modern replacement.
The text highlights the pharmacologic limitations of heparin in percutaneous coronary intervention, advocating for a modern replacement.
A 2000 study conducted a review in Percutaneous coronary intervention. Heparin was evaluated. Heparin has numerous pharmacologic limitations in percutaneous coronary intervention, including variable pharmacokinetics, inability to inhibit clot-bound thrombin, and risk of HIT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: